Roche and Hansoh Sign Cancer Drug Licensing Deal Worth Up to $15 Billion
Roche entered a collaboration and licensing agreement with China's Hansoh for a portfolio of targeted cancer drugs. The deal could exceed $15 billion.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
FACTBOX — Major drugmakers turn to China for licensing deals
(Updates dateline, rewrites lede and adds Roche-Rona Therapeutics deal) Oct 13 (Reuters) — Rona Therapeutics said on Tuesday it has signed a licensing deal worth up to $1.16 billion with Swiss drugmaker Roche for an experimental obesity drug candidate. It is the latest in a wave of deals between Chinese biotech compani